Marquette University

e-Publications@Marquette
College of Nursing Faculty Research and
Publications

Nursing, College of

8-1-1997

Cytokine Profiles of Stimulated Blood
Lymphocytes in Asthmatic and Healthy
Adolescents Cross the School Year
Duck-Hee Kang
The Ohio State University

Christopher L. Coe
University of Wisconsin - Madison

Donna O. McCarthy
Marquette University, donnalee.mccarthy@marquette.edu

Nizar N. Jarjour
University of Wisconsin - Madison

Elizabeth A. Kelly
University of Wisconsin - Madison
See next page for additional authors

Published version. Journal of Interferon and Cytokine Research, Vol. 17, No. 8 (August 1997): 481-487.
DOI. © 1997 Mary Ann Liebert Inc. Used with permission.

Authors

Duck-Hee Kang, Christopher L. Coe, Donna O. McCarthy, Nizar N. Jarjour, Elizabeth A. Kelly, Raymond R.
Rodriguez, and William W. Busse

This article is available at e-Publications@Marquette: https://epublications.marquette.edu/nursing_fac/218

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH 17:481^187 (1997)

Mary

Ann

Liebert, Inc.

Profiles of Stimulated Blood Lymphocytes in
Asthmatic and Healthy Adolescents Across the School Year

Cytokine

DUCK-HEE KANG,1 CHRISTOPHER L. COE,2 DONNA O. MCCARTHY,3 NIZAR N. JARJOUR,4
ELIZABETH A. KELLY,4 RAYMOND R. RODRIGUEZ,4 and WILLIAM W. BUSSE4

ABSTRACT
cell cytokines play an important role in mediating airway inflammation in asthma. The predominance of a
Th2 cytokine profile, particularly interleukin (IL)-4 and IL-5, is associated with the pathogenesis and course
of asthma. The aim of this study was to test the hypothesis that a stressful life event alters the pattern of cy¬
tokine release in asthmatic individuals. Thirteen healthy controls and 21 asthmatic adolescents gave blood
samples three times over a semester: midsemester, during the week of final examinations, and 2—3 weeks af¬
ter examinations. Interferon- (IFN- ), IL-2, IL-4, and IL-5 were measured from supernatants of cells stim¬
ulated with PHA/PMA for 24 h. Cells from asthmatic subjects released significantly more IL-5 during the ex¬
amination and postexamination periods, whereas cells from healthy controls released significantly more IL-2
during the midsemester and examination periods, thereby indicating a bias for a Th2-like pattern in asth¬
matics and a Thl-like pattern in healthy controls. IL-4 and IL-5 production showed a marked decrease dur¬
ing and after examinations in healthy controls, whereas this decline was absent in asthmatics. The ratios of
IFN-y:IL-4 and IFN-y:IL-5 also revealed significant changes in the profile of cytokine release across the se¬
mester. These results indicate differential cytokine responses in asthmatics that may become pronounced dur¬
ing periods of cellular activation.

INTRODUCTION
airway inflammation is a characteristic feature
of asthma, and it has been proposed that activated helper
cells
and their products, cytokines, play a central role in
the regulation of airway inflammation. Two functional subsets
of Th cells have been identified in the immune system: Thl
cells predominantly secrete interleukin-2 (IL-2) and interferony (IFN- ) but little IL-4 and IL-5 and facilitate cell-mediated
immunity. Th2 cells, in contrast, produce IL-4, IL-5, IL-6, and
IL-10 predominantly but little IL-2 and IFN- and participate
in immediate hypersensitivity and allergic reactions.(l_3) Evi¬
dence suggests that the pathogenesis of asthma is associated
with a predominance of Th2-type cytokine production, and
these cytokines may be critical signals initiating and orches¬
trating the complex cellular events in airway inflammation and

Chronic
(Th)

hyperresponsiveness.<4'5)
IL-4 and IL-5

are

two

particularly important cytokines

im¬

plicated in the pathogenesis of asthma. IL-4 is a cell-stimu¬
lating and differentiating factor and an early signal for isotype
switching of cells to produce immunoglobulin E (IgE).(6-7)
Induced production of IgE antibody is a fundamental feature of
allergic asthma. The major functions of IL-5 include the dif¬
ferentiation, maturation, and activation of eosinophils, as well
as the enhancement of eosinophil viability/8'
In allergic asthmatics, peripheral blood (PB) cells were found
to produce significantly more IL-4 and IL-5 than cells from nor¬
mal controls.<9) Similarly, PB cell cultures from atopic children
released higher levels of IL-4 but not - .(10) It was demon¬
strated further that asthmatic individuals had higher percent¬
ages of Circulating cells expressing IL-4 and IL-5 mRNA, a
cellular profile that was decreased with improved lung function
following glucocorticoid treatment/11'
Stress has been found to alter Thl and Th2 cytokine production.(12~15) Stimulated

PB cell cultures showed that acade¬
mic examination stress induced significant changes in the pro-

'College of Nursing, The Ohio State University, Columbus, OH 43210-1289.
2Department of Psychology, 3School of Nursing, and 4Medical School, University of Wisconsin-Madison.
481

482

KANG ET AL.

duction of IL-2 and IFN- . However, the effects of stress on
the levels of IL-4 and IL-5 have not been tested. In view of
long-standing speculation that stress exacerbates asthma symptoms,(16'17) changes in cytokine production are a potential mech¬
anism modulating the relationship between stress and asthma.
The goal of this study, therefore, was to test the hypothesis that
a stressful life event alters the pattern of cytokine release in
asthmatic adolescents. Thl (IL-2 and IFN- ) and Th2 cytokines
(IL-4 and IL-5) were investigated in relation to final examina¬
tion stress, comparing the levels and responsiveness to this
stressful life event between healthy controls and asthmatic in¬
dividuals. In addition, examination-induced changes in
eosinophils, IgE, and peak expiratory flow rates were evalu¬
ated.

SUBJECTS AND METHODS

Thirty-four students were recruited from two local high
schools in Madison, WI. The study protocol was approved by
the school district and Institutional Human Subjects Commit¬
tee, and consent forms were obtained from each student and a
parent. As can be seen in Table 1, subjects were divided into
healthy control, with no known health problems, and asthma
groups I and II, based on medications prescribed. The validity
of this subdivision was also supported by their IgE and blood
eosinophil levels (see Results). Most asthmatic students typi¬
cally used 2 puffs of ß-agonist or steroid inhalants or both twice
a day or as needed. Ninety-four percent of the subjects were
Caucasian (n 32), and there was 1 African American and 1
Asian American. No significant differences were noted in age,
racial distribution, or gender among the three groups. Between
the two asthma groups, however, there were more female sub¬
jects in the Asthma I group than in the Asthma II group.
=

Procedures
Blood samples were collected three times across the fall se¬
of the school year: (1) midsemester in early December
(baseline), (2) during final examination week in mid-January
(Exam), and (3) again 2-3 weeks after final examinations (Post¬
exam). In each period, 5 ml of blood was collected into an
EDTA-containing vacutainer, and 10-20 ml of blood was col¬
lected into a heparinized vacutainer via routine venipuncture
between 7:30 and 8:45 am. EDTA-treated samples were sent to
a local laboratory for complete blood count with differentials.
Heparinized samples were processed for cytokine analyses.
mester

Table 1.

Healthy

13
15.8 d 0.6a

Age (years)

Gender (VIM)
Asthma medication
Asthma duration
aMean ± SD.

Control

(year)

9/4
None

0

sg,

Heparinized blood was layered onto Ficoll-Hypaque (1.077
Sigma) and centrifuged at 450g for 30 min at ambient tem¬

perature. Mononuclear cells (MNC) at the interface between
plasma and Ficoll were carefully harvested and washed twice

saline (PBS without Ca2+,
10 min. The
cells were then resuspended with complete medium (RPMI
1640 supplemented with Hepes 25 mM, L-glutamine 2 mM,
gentamicin 50 ^g/ml, and 10% heat-inactivated fetal bovine
serum, FBS) to give a final cell concentration of 2 X 106/ml.
with sterile

phosphate-buffered

Mg2+, pH 7.4, Gibco) and centrifuged at 450g for

Cytokine

induction and

analyses

Using 24-well flat-bottom cell culture plates, 1 X 106 MNC
in 500 µ\ complete RPMI medium were cultured for 24 h at
37°C with 5% CO2 in the presence of phytohemagglutinin
(PHA, 5 /xg/ml) and phorbol myristate acetate (PMA, 10 ng/ml).
The PHA and PMA cocktail was found to induce maximal cy¬
tokine production from lymphocytes/18' Culture supernatants
70°C until as¬
were then collected and stored in aliquots at
—

sayed.
IFN- , IL-2, IL-4, and IL-5 levels were determined by a stan¬
dard, two-step sandwich, enzyme-linked immunosorbent assay
(ELISA). Briefly, a microtiter plate was coated with a cytokinespecific monoclonal antibody (mouse antihuman IFN- , Endo¬
gen; mouse antihuman IL-2, R&D Systems; and mouse antihuman IL-4 and rat antimouse IL-5, PharMingen). Sample
supernatants were added to the plate, followed by the addition
of a biotinylated antibody directed against the specific cytokine
(polyclonal goat antihuman IFN- , R&D Systems; polyclonal
rabbit antihuman IL-2, PharMingen; and monoclonal rat antihuman IL-4 and IL-5, PharMingen). Biotinylation of the poly¬
clonal antihuman IFN- and IL-2 was performed according to
manufacturer's instructions using an N-hydroxysuccinimide es¬
ter with a long chain sidearm (NHS-LC biotinylation kit, Pierce,
IL). The assay was developed with a streptavidin horseradish
peroxidase homopolymer and the substrate, trimethylbenzidine
(TMB). Cytokine levels were quantitated by comparison to a
standard curve generated from known concentrations of recombinant cytokine. The sensitivity for IL-2, IL-4, IL-5, and
IFN- was less than 25, 3, 3, and 100 pg/ml, respectively.
Blood

analyses

A complete blood count with leukocyte differentials was de¬
termined at a local medical laboratory (General Medical Lab¬
oratories, Madison, WI). Plasma levels of IgE were measured
at the local hospital laboratory.

Subject Characteristics
Asthma I

Asthma II

11
16.0 ± 0.6
7/4
Nonsteroidal
bronchodilator inhalant
7.9 ± 4.7

10
16.2 ± 0.8
3/7
Steroidal and
nonsteroidal inhalant
9.7 ± 5.2

483

CYTOKINE PROFILES IN ASTHMA

Peak

expiratory flow

rate

(PEFR)

Peak expiratory flow rate (PEFR) was measured in asthmatic
subjects only. Asthmatic subjects were provided with an As¬
Peak Flow Meter (HealthScan, Cedar Grove, NJ) and asked
peak flow readings daily for 2 weeks in each period.
were
instructed to perform three peak flows at bed¬
Subjects
time before taking asthma medications and to record the high¬
est value in the diary. Before this diary assignment, all subjects
were trained on how to use the flow meter correctly until they
demonstrated proficiency. The Assess Peak Flow Meter was
tested to be highly accurate and reproducible, with an average
flow error <0.25%/19>
sess

to record

Statistical
Data

analysis

were

analyzed using

SPSS statistical software. Re¬

analysis of variance (ANOVA) was employed
peated
to analyze the significance of overall group differences, changes
in cytokine production, and cell responses across the three time
points (Baseline, Exam, and Postexam), and group X time in¬
teractions. When appropriate, one-way ANOVA was used to
determine group differences at each time, with specific con¬
trasts between healthy control and asthmatic groups. In addi¬
tion, correlational analyses were performed using Pearson prod¬
measures

uct-moment

significant differences in the levels of IL-2 and IL-5 be¬
healthy control and asthma groups. During the Base¬
line period, cells from healthy controls produced significantly
more IL-2 than did cells from asthmatics, particularly in com¬
0.04
parison with the asthma II group: F(2,31) 3.49,
were

correlations.

tween the

=

=

0.026 between the
among the three groups; t(31) 2.34,
control
and
combined
asthma
groups. In contrast, the
healthy
was
in asthmatic sub¬
of
IL-5
significantly
higher
production
jects during the Postexam period, when both asthma groups had
more than threefold higher levels of IL-5 than control subjects:
F(2,23) 4.72,/? < 0.02 among the three groups; t(23) 3.07,
0.005 between the healthy control and combined asthma
groups. A similar pattern of significant differences was found
in the IL-2 and IL-5 responses during the Exam period between
healthy control and asthma groups (Table 2). IL-4 and IFNproduction, however, was not different among the three groups.
In addition, the overall level of IL-4 released from the cells was
considerably lower than the levels of the other cytokines.
Because of the purported role of Th2 cytokines in the patho¬
genesis of asthma, we examined whether there were differences
between healthy and asthmatic subjects in the ratios of Thl vs.
Th2 cytokines. In this regard, the levels of IL-2 and IFN- were
examined with respect to IL-4 and IL-5. The ratio data were trans¬
formed by base 10 logarithm to generate a normal distribution
of the data. The IL-2:IL-5 ratio provided the greatest distinction
among the three groups. Repeated measures ANOVA indicated
a significant group difference, F(2,23)
5.07, < 0.02.
As illustrated in Table 3, specific contrasts between healthy
control and asthma groups showed that healthy controls had
significantly higher ratios of IL-2:IL-5 than asthmatic subjects
at all time points. Similarly, the ratios of
- : -5 also were
significantly higher in healthy controls than in asthmatics dur¬
ing the Exam and Postexam periods. IL-2 and IFN- ratios with
respect to IL-4 levels, however, did not differ between groups.
=

=

=

=

—

=

RESULTS

Cytokine and blood profiles of the

groups

Cytokine Profile. The levels of cytokine production, as well
the ratios of Thl/Th2 cytokines, were examined in asthmatic
and healthy control subjects. As can be seen in Table 2, there
as

Table 2.

Cytokine Levels (pg/ml)

from

Supernatant Following 1-Day Culture

of

Cells

with

PHA/PMA Cocktail

(healthy
asthma)

Contrast

Healthy
(n 13)
=

Asthma I

(n

=

11)

Asthma IL

(

=

vs.

10)

IL-2

Baseline
Exam
Postexam

13922 ± 1547a
12179 ± 1255
9437 ±1361

11510
9349
11736

1249
771
1261

8965 ± 904
9246 ± 1333
9479 ± 1377

0.026b
0.047b

3143 ± 800
4044 ± 732
2712 ± 515

2334
2546
2911

452
809
760

1696 ± 389
3640 ± 674
2564 ± 994

0.131
0.289
0.978

22.2 ± 3.5
17.3 ± 2.7
12.1 ± 2.8

15.4
13.2
14.6

2.3
4.0
3.4

14.2
14.0
19.9

936
934
926

209
247
239

830 ± 182
926 ± 205
1083 ± 193

IFNBaseline
Exam
Postexam
IL-4
Baseline
Exam
Postexam
IL-5
Baseline
Exam
Postexam
aMean ± SE.
bp values reflect

842 ± 316
388 ± 125
293 ± 112

significance of differences between healthy

and combined asthmatic

0.398

0.069
0.338
0.313

3.9
3.1
5.8

subjects

0.894
0.02 lb

0.005b
at

the level

<

0.05.
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Table 3.

Th1/Th2 Cytokine Ratios

from

Supernatant Following 1-Day Culture

of

Cells

with

PHA/PMA Cocktail

(healthy
asthma)

Contrast

Healthy

(n
IL-2: IL-5
Baseline
Exam
Postexam
IFN- : IL-5
Baseline
Exam
Postexam
IL-2: IL-4
Baseline
Exam
Postexam
IFN- : IL-4
Baseline
Exam
Postexam

=

13)

Asthma I

Asthma II

(n

(n

=

0.15a
0.15
0.15

1.23
1.18
1.25

0.14
0.13
0.15

1.08
1.06
0.95

0.08
0.12
0.06

0.029b
0.00 lb
0.004b

0.60
1.19
1.06

0.28
0.17
0.13

0.43
0.39
0.53

0.22
0.21
0.21

0.25
0.67
0.16

0.12
0.08
0.20

0.344

0.003b
0.004b

2.85
2.97
2.82

0.08
0.17
0.07

2.91
2.98
3.01

0.10
0.14
0.13

2.82
2.83
2.78

0.09
0.11
0.10

0.86
0.74
0.59

1.92
2.43

0.19
0.18
0.09

2.10
2.20
2.29

0.18
0.19
0.12

2.02
2.44
2.05

0.09
0.12
0.12

0.49
0.61
0.61

healthy

and combined asthmatic

"Mean ± SE.
hp values reflect significance of differences between
transformed by base 10 logarithm.

Blood Analysis. As expected, plasma levels of IgE indicated
significant overall group difference across the three time
0.025, respectively. The average
points: F(2,28) 4.24,
levels of IgE were almost 10 times higher in asthmatics than in
a

=

controls: F(2,31) 5.90,
0.007 for Baseline, F(2,30)
0.017
3.63, < 0.04 during Exams, and F(2,28) 4.73,
during the Postexam period, respectively (Fig. 1). Asthma II
subjects also had higher mean levels of IgE than did asthma I
subjects at all time points. Similarly, both the overall percent¬
age and absolute number of eosinophils were significantly
higher in asthmatic subjects than in healthy controls: F(2,23)
0.02 and F(2,23) 5.03,
4.66,
0.015, respectively
statistics for the absolute number of eosinophils
1
The
).
(Fig.
showed that the differences were most evident during the Base¬
line period.
Pulmonary Function. PEFRs were measured in asthmatic in¬
dividuals only. The two asthmatic groups did not differ in the
peak flow expiratory rates, although it should be reiterated that
the asthma II group required more medication to maintain their
lung function and had more males than the asthma I group. In
a subset of asthmatics who measured their baseline peak flow
rates in the morning and at bedtime (7 in the asthma I and 5 in
the asthma II groups), the decrease in flow rates at bedtime was
more prominent in asthma II subjects: -5.4 vs. -39.3 L/min.
=

10)

=

1.52
1.73
1.66

2.24

=

11)

vs.

=

=

=

=

subjects

at the level

<

0.05. Data

are

riod, which

was sustained above baseline values during the
Postexam period, whereas this pattern was less clear in the two
asthma groups (Fig. 2).
Blood Profile. The levels of IgE and eosinophil numbers and
percent did not change significantly across the three time points.
Pulmonary Function. PEFRs were also not affected by the
examinations. The flow rates remained stable throughout the
school semester.

Correlations between

cytokines

and blood profiles

=

=

Effect of examination

=

=

stress

Cytokine Profile. Despite a number of group differences in
cytokine profiles between healthy controls and asthmatic sub¬
jects, we did not find significant changes in the production of
any single cytokine across the examination period. The most
notable changes over time were noted in the ratios of IFN-y:IL5 and IFN-rIL-4: F(2,44) 5.00,
0.01, and F(2,44)
6.40,
0.004, respectively. Healthy controls demonstrated a
marked increase in these cytokine ratios during the Exam pe¬
=

=

=

=

The two Thl-type cytokines, IL-2 and IFN- , were signifi¬
cantly correlated during the Baseline and Postexam periods (r
0.48,
0.005, and r 0.49,
0.005, respectively), but this
relationship weakened during the Exam period (r 0.29,
0.11). In contrast, Th2-type cytokines, IL-4 and IL-5, were not
significantly correlated at any time point. Interestingly, how¬
ever, there were consistently high correlations between IL-4 and
IFN- across the three time points: r 0.42, < 0.02 during
0.03 during the Exam period, and r
Baseline, r 0.37,
0.003 in the Postexam period, respectively.
0.52,
Because of the known effects of IL-5 on eosinophil activity,
we also examined the relationship between IL-5 and
eosinophils. IL-5 levels were not significantly correlated with
either eosinophil number or percent at any time point. Simi¬
larly, IL-4 levels were not correlated with IgE. However, IgE
level was significantly correlated with eosinophil number dur¬
ing the Exam period, r 0.42, < 0.02.
=

=

=

=

=

=

=

=

=

=

=

=

DISCUSSION
The main goal of this study was to test the hypothesis that
stressful event, such as final examinations, alters cytokine pro¬
duction in asthmatic adolescents. Unlike the previous reports
a

485

CYTOKINE PROFILES IN ASTHMA
12

2.7

-,

Baseline

Exam

Group differences in eosinophil percent (top) and IgE
(bottom). Eosinophil percent differed significantly between the
healthy and asthma II groups during Baseline and Exam peri¬
ods. This group difference between healthy and asthma II sub¬
jects extended to IgE levels at each time point.
FIG. 1.

of a significant reduction in IFN- and an increase in IL-2 pro¬
duction by lymphocytes during the examination period in med¬
ical students/12-14' we did not observe any significant changes
in the in vitro release of individual cytokines, IL-2, IFN- , IL4, and IL-5, that was restricted to the examination period. In¬
stead, the pattern of IL-5 production during both the Exam and
Postexam periods was found to differ between healthy and asth¬
matic subjects. Healthy subjects showed a considerable decline
in IL-5 production during the Exam and Postexam periods (/;
0.055), whereas asthmatics did not show the examinationinduced decrease in IL-5. A similar pattern was found in IL-4
production. These decreases in the production of IL-4 and IL5 appear to largely account for the sustained increases in the
IFN^:IL-4 and the IFN-^IL-5 ratios in healthy subjects dur¬
ing the Exam and Postexam periods.
The clinical significance of this difference in cytokine pat¬
tern is not clear. Although it was not associated with a shift in
pulmonary function during the Exam period, it should be reit¬
erated that asthmatic subjects were allowed to continue their
asthma medications, both steroid and nonsteroid inhalants.
=

Baseline

Exam

Postexam

FIG. 2. Changes in the
- . -4 ratio (top) and - : 5 ratio (bottom) over time. Significant changes were found in
both Thl/Th2 ratios across the examination. For the IFN-^IL5 ratio, there was a significant group X time interaction, indi¬
cating a significantly different pattern of response over time
among the three groups.

throughout the study to evaluate changes in a normative situa¬
tion. Although the effects of these inhalants are mostly local,
one cannot completely rule out their possible effects on pe¬
ripheral blood cell function.
Overall, cytokine profiles of cells from asthmatic subjects
reflected a Th2-like predominance, whereas the cell response
from healthy control subjects was more indicative of a Thl-like
predominance. Specifically, cells from asthmatic subjects pro¬
duced significantly more IL-5 than did the cells from healthy
controls across the Exam and Postexam periods. In contrast,
proliferating cells from control subjects generated significantly
higher levels of IL-2 during the Baseline and Exam periods fol¬
lowing stimulation with the PHA/PMA cocktail. These patterns
were supported further when the balance between Thl and Th2
cytokines was evaluated. Healthy control subjects showed sig¬
nificantly higher ratios of IL-2:IL-5 as well as IFN-yIL-5 than
did the asthmatic students.
These findings are consistent with other studies

reporting

a
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predominant Th2-pattern in asthmatic subjects/20-22' Asthmat¬
ics, particularly during an acute, symptomatic period or with
severe asthma, typically present a strong bias for IL-4 and IL5 production when cells are obtained from either bronchoalve¬
olar lavage or PB. The overproduction of IL-4, however, may
be more a feature of an atopic state than a characteristic of
asthma/10' Although IL-4 can effectively induce the produc¬
tion of IgE/23' the correlations between peripheral blood IgE
production and IL-4 level have not been consistent/24' In our
study, IL-4 levels did not directly correlate with the plasma
level of IgE, nor did they correlate with IL-5 levels in the su¬
pernatant sample.
Higher IL-5 and eosinophil values in asthmatics appear to
support the purported relationship between IL-5 and eosinophil
function in the pathology of asthma. Other researchers have re¬
ported that the percentage of Th cells expressing IL-5 mRNA
was highly correlated with eosinophil counts in asthmatics/11'
Moreover, improvement in pulmonary function following an
oral glucocorticoid therapy coincided with reduced percentages
of IL-5 mRNA encoding cells, as well as decreased IL-5 se¬
cretion and eosinophil count/11-25' In our study, however, the
IL-5 levels induced from mononuclear cells were not directly
correlated in a linear manner with the blood eosinophil num¬
bers.

Although we did not find significant correlations between
pulmonary function, as measured by PEFR, and cytokine lev¬
els, this result may have been influenced by the relatively sta¬
ble and mild form of asthma. Asthmatic students in this study
appeared to be medically well managed, and the continued use
of daily medication may have mitigated against any exacerba¬
tion of symptoms during the stress of examinations. The influ¬
of stress may have been more evident if the medication
had been controlled and a more severe form of asthma had been
studied.
ence
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